Weekly Evolent Health, Inc. (NYSE:EVH) Ratings

June 29, 2018 - By Sarah Holford

Evolent Health, Inc. (NYSE:EVH) Corporate Logo

Evolent Health, Inc. (NYSE:EVH) Ratings Coverage

In total 11 analysts cover Evolent Health (NYSE:EVH). “Buy” rating has 9, “Sell” are 0, while 2 are “Hold”. (NYSE:EVH) has 82% bullish analysts. 14 are the (NYSE:EVH)’s ratings reports on Jun 29, 2018 according to StockzIntelligence Inc. On Tuesday, April 24 the rating was reinitiated by JP Morgan with “Neutral”. On Wednesday, February 28 the stock has “Buy” rating by Canaccord Genuity. On Monday, May 14 the rating was maintained by Robert W. Baird with “Buy”. On Wednesday, May 30 the firm earned “Overweight” rating by KeyBanc Capital Markets. On Wednesday, January 10 the firm earned “Buy” rating by KeyBanc Capital Markets. On Tuesday, April 24 the company was downgraded by J.P. Morgan. On Tuesday, February 13 Jefferies maintained Evolent Health, Inc. (NYSE:EVH) with “Buy” rating. On Thursday, June 7 the firm has “Overweight” rating by KeyBanc Capital Markets given. The company rating was maintained by SunTrust on Thursday, June 7. On Wednesday, February 28 Wells Fargo maintained the shares of EVH in report with “Outperform” rating. Listed here are Evolent Health, Inc. (NYSE:EVH) PTs and latest ratings.

07/06/2018 Broker: SunTrust Rating: Buy New Target: $30.0000 Maintain
07/06/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $24 New Target: $26 Maintain
04/06/2018 Broker: PiperJaffray Rating: Overweight New Target: $30 Initiates Coverage On
04/06/2018 Broker: Piper Jaffray Rating: Buy New Target: $30.0000 Initiate
30/05/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $19 New Target: $24 Maintain
14/05/2018 Broker: Robert W. Baird Rating: Buy New Target: $25.0000 Maintain
24/04/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Neutral Reinitiate
24/04/2018 Broker: J.P. Morgan Rating: Hold New Target: $17.0000 Downgrade
28/02/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $27 New Target: $24 Maintain
28/02/2018 Broker: Wells Fargo Rating: Outperform Old Target: $27 New Target: $20 Maintain

Ticker’s shares touched $21.725 during the last trading session after 0.80% change.Currently Evolent Health, Inc. is downtrending after 16.53% change in last June 29, 2017. EVH has also 109,295 shares volume. The stock underperformed the S&P500 by 29.10%.

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States.The firm is worth $1.69 billion. It operates as a managed services firm that supports integrated health systems in migration toward value care and population health management.Last it reported negative earnings. The companyÂ’s services include providing clients with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services.

More recent Evolent Health, Inc. (NYSE:EVH) news were announced by Seekingalpha.com, Nasdaq.com and Streetinsider.com. The first one has “Premarket analyst action – healthcare” as a title and was announced on June 04, 2018. The next is “Report: Developing Opportunities within RealNetworks, Acacia Communications, Medical Transcription Billing, Evolent …” on June 11, 2018. And last was announced on June 18, 2018, called “Evolent Health (EVH) PT Raised to $31 at Oppenheimer Following Market Analysis”.

Evolent Health, Inc. (NYSE:EVH) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.